Seelos Therapeutics
New York
About Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2024)
- Ticker: nasdaq:SEEL
- Website: seelostherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/seelos-therapeutics-123356 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.